Director at the Mayo Clinic and Mayo Clinic Laboratories In Rochester, Minnesota; Associate Professor of Medicine and Laboratory Medicine, Mayo Clinic College of Medicine and Science
BIOGRAPHY
JUN 07, 2022 10:00 AM PDT
New 2021 CDC HIV PrEP (Preexposure Prophylaxis) Guidelines: Implications for Clinicians and Laboratories
Speaker
Date & Time
Date: June 07, 2022
Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST)
Abstract
On December 8th, 2021 the CDC released new recommendations for preexposure prophylaxis (PrEP) for the prevention of HIV infection in the US. These new guidelines include important updates designed to help increase access to and awareness of PrEP as well as new recommendations for laboratory testing. This webinar will review these important changes and discuss how they will impact patients, clinicians, and the clinical laboratories providing results that play a critical role in this updated approach.
Learning Objectives
- Outline current HIV/PrEP landscape in the US
- Describe important changes in the new 2021 CDC PrEP Guidelines
- Review rationale of new recommendations for NAAT in PrEP monitoring and potential impact on clinical laboratories, clinicians, and patients
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
JAN 14, 2026 | 10:00 AM
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge and accurate, timely diagnosis is cri...
JAN 15, 2026 | 8:00 AM
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
JAN 20, 2026 | 11:00 AM
CAR-T translational research demands precise, reproducible, and scalable flow cytometry workflows. Manual centrifugation and antibody preparation steps remain major sources of variability an...
JAN 20, 2026 | 9:15 AM
Bloodstream infections (BSIs) remain a critical challenge in clinical care, where every hour of delay in diagnosis can significantly impact patient outcomes. This webinar explores findings f...
JAN 21, 2026 | 8:45 AM
C.E. CREDITS
Lipid nanoparticles (LNPs) have become the gold standard in non-viral gene delivery technologies, exemplified by the approval of the LNP messenger RNA (mRNA) vaccines against SARS-CoV-2. Sin...
JAN 22, 2026 | 8:00 AM
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
Loading Comments...